Online citations, reference lists, and bibliographies.
← Back to Search

Low-Dose Intravaginal Estriol And Pelvic Floor Rehabilitation In Post-Menopausal Stress Urinary Incontinence

Daniele Castellani, P. Saldutto, Vikiela Galica, G. Pace, Daniela Biferi, G. Paradiso Galatioto, C. Vicentini
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Introduction: Pelvic floor muscle training (PFMT) and electrical stimulation (ES) are conservative models of therapy for treating female stress urinary incontinence (SUI). The presence of estradiol receptors in the lower urinary tract advances the case for estradiol therapy in SUI. The aim of our study was to investigate the effects of the combination of pelvic floor rehabilitation and intravaginal estriol (IE) on SUI treatment in postmenopausal women. Material and Methods: Sixty-two women with SUI were randomized to PFMT, ES and biofeedback (Group 1) or the same treatment plus 1 mg IE (Group 2) for 6 months. Patients were evaluated with medical history, pelvic examination, urodynamics, 24-hour pad test. Urinary incontinence was evaluated using the International Consultation on Incontinence questionnaire on urinary incontinence short form and quality of life using the Incontinence Impact Questionnaire-Short Form. Results: Two patients were lost at follow-up and one discontinued the study. Mean urine leakage at the 24-hour pad test dropped from 42.3 ± 20.2 g/die to 31.5 ± 14.2 g/die in Group 1 and from 48.3 ± 19.8 g/die to 22.3 ± 10.1 g/die in Group 2. Symptoms scores and incontinence status were statistically significant better in Group 2 when compared to Group 1. Conclusion: IE added to PFMT, ES and BF is a safe and efficacious first-line therapy in postmenopausal women with SUI.
This paper references
Estrogen receptors in the human female lower uninary tract.
C. Iosif (1981)
Analysis of Collagen Status in Premenopausal Nulliparous Women With Genuine Stress Incontinence
D. Keane (1998)
Estrogen Receptors in the Human Female Lower Urinary Tract
C. Iosif (1982)
Postmenopausal Hormone Therapy and Risk of Developing Urinary Incontinence
A. Wein (2004)
Lifetime Risk of Stress Urinary Incontinence or Pelvic Organ Prolapse Surgery
J. Wu (2014)
Effects of estrogen with and without progestin on urinary incontinence.
S. Hendrix (2005)
Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women
C. Iosif (2007)
Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure‐flow studies * *
W. Schaefer (2002)
Short forms to assess life quality and symptom distress for urinary incontinence in women: The incontinence impact questionnaire and the urogenital distress inventory
J. S. Uebersax (1995)
Englev E: Estradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms
G Lose (2000)
The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.
R. Bump (1996)
ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence
K. Avery (2004)
Oestrogen therapy for urinary incontinence in post-menopausal women.
J. Cody (2009)
Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women
G. Capobianco (2011)
Oestradiol‐releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms
G. Lose (2000)
Estrogens and the lower urinary tract
D. Robinson (2011)
Postmenopausal Hormones and Incontinence: The Heart and Estrogen/Progestin Replacement Study
D. Grady (2001)
Oestrogen therapy for urinary incontinence in post-menopausal women.
June D Cody (2012)
Definition of mild, moderate and severe incontinence on the 24‐hour pad test
R. O'Sullivan (2004)
Effects of intra - vaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal wom
G Capobianco (2012)
Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence
L. Edwall (2007)
Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials
L. Berghmans (2000)
Effects of estrogen on urethral function in women with urinary incontinence.
N. Bhatia (1989)
Physiologic therapy for urinary stress incontinence.
A. Kegel (1951)
Corrigendum to “EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence” [Eur Urol 2012;62:1130–42]
M. Lucas (2013)
The use of intravaginal oestrogen cream in genuine stress incontinence
P. Hilton (1983)
EAU guidelines on assessment and nonsurgical management of urinary incontinence.
M. Lucas (2012)
Estrogen Therapy in the Management of Urinary Incontinence in Postmenopausal Women: A Meta-Analysis. First Report of the Hormones and Urogenital Therapy Committee
J. A. Fantl (1994)
Prevalence of Genitourinary Symptoms in the Late Menopause
C. Iosif (1984)
Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women
S. Dessole (2004)
Prevalence and incidence of urinary incontinence in women: Review of the literature and investigation of methodological issues
Roslin Botlero (2008)
Different organization of collagen fibrils in stress‐incontinent women of fertile age
C. Falconer (1998)
Is It Possible to Predict Urodynamic Stress Urinary Incontinence in Women with Minimal Diagnostic Evaluation?
Bulent Cetinel (2014)
Urethral Sphincteric Insufficiency in Postmenopausal Females: Treatment with Phenylpropanolamine and Estriol Separately and in Combination. A Urodynamic and Clinical Evaluation
B. Ho (1985)
Effects of vaginally-administered oestriol on post-menopausal urogenital disorders: a cytohormonal study.
G. Heimer (1992)
Safety and Efficacy of Retropubic or Transobturator Midurethral Slings in a Randomized Cohort of Turkish Women
Tufan Tarcan (2014)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar